PALB2 and breast cancer: Chemotherapy receipt varied significantly by pathogenic variant and age at diagnosis, with BRCA1 carriers, PALB2 carriers, and early-onset breast cancers diagnosed under 30 years of age receiving chemotherapy in greater than 80% of cases (Table 2).